{"altmetric_id":470624,"counts":{"readers":{"mendeley":1,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["AJCOonline"],"posts_count":1}},"citation":{"abstract":"Bortezomib, a proteasome inhibitor, has synergistic antitumor activity with gemcitabine, an antimetabolite, in preclinical and clinical studies. The safety of this combination has not yet been established in elderly patients; therefore, this dose-escalation study was designed to assess the maximum-tolerated dose of bortezomib and gemcitabine in patients aged 70 years or older with advanced-stage solid tumors.","abstract_source":"pubmed","altmetric_jid":"4f6fa6083cf058f61000696c","doi":"10.1097\/coc.0b013e3181f9441f","first_seen_on":"2011-11-26T22:51:07+00:00","issns":["0277-3732"],"issue":"6","journal":"American Journal of Clinical Oncology: Cancer Clinical Trials","last_mentioned_on":1322346668,"links":["http:\/\/journals.lww.com\/amjclinicaloncology\/Abstract\/2011\/12000\/Phase_1_Trial_of_Gemcitabine_With_Bortezomib_in.8.aspx"],"pdf_url":"http:\/\/pdfs.journals.lww.com\/amjclinicaloncology\/2011\/12000\/Phase_1_Trial_of_Gemcitabine_With_Bortezomib_in.8.pdf","pmid":"21127410","pubdate":"2011-12-01T00:00:00+00:00","publisher_subjects":[{"name":"Dentistry","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"startpage":"597","subjects":["neoplasms"],"title":"Phase 1 Trial of Gemcitabine With Bortezomib in Elderly Patients With Advanced Solid Tumors","type":"article","volume":"34","mendeley_url":"http:\/\/www.mendeley.com\/research\/phase-1-trial-gemcitabine-bortezomib-elderly-patients-advanced-solid-tumors"},"altmetric_score":{"score":0.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":4506935,"mean":5.125739366827,"rank":3094753,"this_scored_higher_than_pct":21,"this_scored_higher_than":969417,"rank_type":"exact","sample_size":4506935,"percentile":21},"similar_age_3m":{"total_number_of_other_articles":229752,"mean":4.1874696954532,"rank":143606,"this_scored_higher_than_pct":21,"this_scored_higher_than":49673,"rank_type":"exact","sample_size":229752,"percentile":21},"this_journal":{"total_number_of_other_articles":756,"mean":1.2420688741722,"rank":409,"this_scored_higher_than_pct":9,"this_scored_higher_than":72,"rank_type":"exact","sample_size":756,"percentile":9},"similar_age_this_journal_3m":{"total_number_of_other_articles":31,"mean":0.71666666666667,"rank":13,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":31,"percentile":1}}},"demographics":{"poster_types":{"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Student  > Doctoral Student":1},"by_discipline":{"Agricultural and Biological Sciences":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/AJCOonline\/status\/140558231427751937","citation_ids":[470624],"posted_on":"2011-11-26T22:31:08+00:00","author":{"name":"AJCO","url":"http:\/\/amjclinicaloncology.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1095553832\/AJCO_normal.jpg","description":"AJCO is a multidisciplinary journal for cancer surgeons, radiation oncologists, medical oncologists, GYN oncologists, and pediatric oncologists.","id_on_source":"AJCOonline","tweeter_id":"174745137","geo":{"lt":null,"ln":null},"followers":75},"tweet_id":"140558231427751937"}]}}